Physiopathology and pharmacotherapy of occlusive arterial disorders.
D001157:Arterial Occlusive Diseases / Q000503:physiopathology*; D001161:Arteriosclerosis / Q000150:complications; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000503:physiopathology; D001809:Blood Viscosity; D002561:Cerebrovascular Disorders / Q000209:etiology; D002791:Cholesterol, Dietary / Q000009:adverse effects; D003097:Collateral Circulation; D003327:Coronary Disease / Q000209:etiology; D006801:Humans; D006940:Hyperemia / Q000209:etiology; D006973:Hypertension / Q000209:etiology; D009119:Muscle Contraction; D010974:Platelet Aggregation / Q000187:drug effects; D012306:Risk; D013927:Thrombosis / Q000517:prevention & control; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use
D002791:Cholesterol, Dietary; D014665:Vasodilator Agents; D001241:Aspirin